This review summarizes existing knowledge about phenotypic variability in myotonia congenita and discusses possible contributing factors.
Answers are grounded in this paper and cite their sources.
Variable severity despite shared mutations cautions against genotype-based prognostication in myotonia congenita; leaves open identification of modifying factors.
Myotonia congenita is a hereditary chloride channel disorder characterized by delayed relaxation of skeletal muscle (myotonia). It is caused by mutations in the skeletal muscle chloride channel gene CLCN1 on chromosome 7. The phenotypic spectrum of myotonia congenita ranges from mild myotonia disclosed only by clinical examination to severe and disabling myotonia with transient weakness and myopathy. The most severe phenotypes are seen in patients with two mutated alleles. Heterozygotes are often asymptomatic but for some mutations heterozygosity is sufficient to cause pronounced myotonia, although without weakness and myopathy. Thus, the phenotype depends on the mutation type to some extent, but this does not explain the fact that severity varies greatly between heterozygous family members and may even vary with time in the individual patient. In this review, existing knowledge about phenotypic variability is summarized, and the possible contributing factors are discussed.
No takes yet. Share an insight, caveat, or question.
Eskild Colding‐Jørgensen (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: